| |
| |
|
| Insider
Information: |
Bishop John E |
| Relationship: |
SVP, Chief Technology ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
157,253 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,252,637 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,253 |
|
|
| Total
Value |
$8,252,637 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Pharmaceuti... |
2016-05-19 |
157,253 |
2006-02-17 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
SVP, Chief Technology ... |
2022-10-14 |
0 |
2021-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
167 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-02-25 |
4 |
AS |
$13.20 |
$845 |
D/D |
(64) |
124,943 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-02-23 |
4 |
AS |
$13.26 |
$4,084 |
D/D |
(308) |
55,362 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2013-05-15 |
4 |
AS |
$13.33 |
$3,333 |
D/D |
(250) |
101,204 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-02-20 |
4 |
AS |
$13.40 |
$3,042 |
D/D |
(227) |
125,347 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-02-22 |
4 |
AS |
$13.45 |
$15,938 |
D/D |
(1,185) |
45,472 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-02-24 |
4 |
AS |
$13.56 |
$2,861 |
D/D |
(211) |
125,007 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-08-10 |
4 |
S |
$13.58 |
$101,646 |
D/D |
(7,485) |
95,963 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-08-23 |
4 |
AS |
$13.64 |
$3,246 |
D/D |
(238) |
95,481 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-06-16 |
4 |
AS |
$13.69 |
$5,873 |
D/D |
(429) |
49,549 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-08-21 |
4 |
AS |
$13.78 |
$3,362 |
D/D |
(244) |
95,719 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-02-28 |
4 |
AS |
$13.85 |
$3,933 |
D/D |
(284) |
55,078 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-05-21 |
4 |
AS |
$13.87 |
$3,370 |
D/D |
(243) |
103,921 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-05-29 |
4 |
AS |
$13.93 |
$3,246 |
D/D |
(233) |
103,448 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-03-15 |
4 |
AS |
$13.94 |
$6,078 |
D/D |
(436) |
54,642 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-06-15 |
4 |
AS |
$14.00 |
$5,964 |
D/D |
(426) |
49,978 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-08-28 |
4 |
AS |
$14.35 |
$3,329 |
D/D |
(232) |
95,249 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2014-03-04 |
4 |
AS |
$14.41 |
$922 |
D/D |
(64) |
111,069 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-12-15 |
4 |
AS |
$14.42 |
$6,143 |
D/D |
(426) |
47,083 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2013-08-20 |
4 |
AS |
$14.47 |
$3,140 |
D/D |
(217) |
100,273 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-08-29 |
4 |
S |
$14.57 |
$34,924 |
D/D |
(2,397) |
92,852 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-03-17 |
4 |
AS |
$14.59 |
$8,637 |
D/D |
(592) |
51,002 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-03-01 |
4 |
AS |
$14.65 |
$16,891 |
D/D |
(1,153) |
51,594 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-12-16 |
4 |
AS |
$14.83 |
$6,318 |
D/D |
(426) |
46,657 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-06-17 |
4 |
AS |
$14.88 |
$37,170 |
D/D |
(2,498) |
49,549 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-03-18 |
4 |
AS |
$14.88 |
$37,155 |
D/D |
(2,497) |
54,642 |
0 |
- |
|
167 Records found
|
|
Page 4 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
